Oak Associates Ltd. OH decreased its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 0.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 108,812 shares of the technology company’s stock after selling 825 shares during the period. Oak Associates Ltd. OH owned 0.10% of Amdocs worth $9,264,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Pzena Investment Management LLC grew its holdings in shares of Amdocs by 4.3% during the 4th quarter. Pzena Investment Management LLC now owns 6,634,549 shares of the technology company’s stock worth $564,866,000 after purchasing an additional 270,810 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Amdocs by 2.8% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company’s stock worth $274,681,000 after buying an additional 87,801 shares during the period. Vanguard Group Inc. increased its position in shares of Amdocs by 16.1% in the fourth quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company’s stock worth $261,756,000 after acquiring an additional 426,035 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Amdocs by 25.4% in the 4th quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company’s stock valued at $228,211,000 after acquiring an additional 543,490 shares during the period. Finally, Pacer Advisors Inc. lifted its holdings in shares of Amdocs by 7.4% during the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock valued at $154,587,000 after acquiring an additional 125,654 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs Price Performance
Shares of DOX stock opened at $82.21 on Friday. The firm has a fifty day simple moving average of $87.75 and a 200-day simple moving average of $87.28. The company has a market capitalization of $9.28 billion, a PE ratio of 19.07, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $93.34. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.527 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a dividend yield of 2.56%. The ex-dividend date is Monday, March 31st. Amdocs’s dividend payout ratio is 48.72%.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Amdocs currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- The Basics of Support and Resistance
- Energy Transfer: Tariff-Resistant Midstream Resilience
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Marvell Gets Tariff Lifeline But Expect More Volatility
- What Do S&P 500 Stocks Tell Investors About the Market?
- Greenbrier: Don’t Buy It For Revenue Growth—Buy It For Margin
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.